Navigation Links
Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
Date:4/14/2008

cromet-inc.com" target="_new">(http://www.micromet-inc.com)

Micromet, Inc. is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Three of its antibodies are currently in clinical trials, while the remainder of the product pipeline is in preclinical development. The BiTE(R) antibody MT103 is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and in a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. BiTE antibodies represent a new class of antibodies that activate a patient's own cytotoxic T cells, considered the most powerful "killer cells" of the human immune system, to eliminate cancer cells. Micromet is developing MT103 in collaboration with MedImmune, Inc., a subsidiary of AstraZeneca plc. The second clinical stage antibody is adecatumumab, also known as MT201, a human monoclonal antibody which targets epithelial cell adhesion molecule (EpCAM)-expressing solid tumors. Micromet is developing adecatumumab in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. The third clinical stage antibody, MT293 is licensed to TRACON Pharmaceuticals, Inc. and is being developed in a phase 1 clinical trial for the treatment of patients with cancer. In addition, Micromet has established a collaboration with Nycomed for the development and commercialization of MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or multiple sclerosis.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual result
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet Announces Changes in Management Team
2. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
3. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
4. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
5. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
6. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
7. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
8. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
10. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
11. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 According ... Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), ... - Analysis & Global Forecast to 2020", published by ... to reach around $957.9 Million by 2020 with a ... Browse 116 market T ables and 33 ...
(Date:7/1/2015)... , July 1, 2015  Celsion Corporation (NASDAQ: ... announced that Michael H. Tardugno , Chairman, President ... Fitzgerald,s Inaugural Healthcare Conference on Wednesday, July 8, 2015, ... at Le Parker Meridien Hotel located at 119 W. ... 10019. A copy of the presentation will ...
(Date:7/1/2015)... July 1, 2015 Radiant Insights ... Stationary Oxygen Concentrators Market Shares, Strategy, and Forecasts, ... achieve continuing growth as the aging population worldwide needs ... respiratory conditions where oxygen is able to improve the ... devices have become affordable and support a mobile lifestyle ...
Breaking Medicine Technology:Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 4Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4
(Date:7/1/2015)... ... July 01, 2015 , ... A healthy eating plan ... and eggs. Eating organic foods and products can help limit the exposure to ... than production chicken farming. Choosing home raised chickens and eggs that do not ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... global cancer enterprise of Hospital Corporation of America (HCA), as it further expands ... OncLive announced today. , With this new partnership, OncLive’s editorial and marketing ...
(Date:7/1/2015)... Springs, Colorado) , ... - (PRWEB) July 01, 2015 , ... ... hosting a nationwide virtual 5K on August 15-16th (MSG Keys’ birthday) in memory of ... Keys, a highly decorated soldier and recipient of the Bronze Star Medal, died during ...
(Date:7/1/2015)... Louisville, KY (PRWEB) , ... July 01, 2015 ... ... Health Care Transformation Task Force, contributing to newly released white paper: “Pro-actively Identifying ... The paper was published July 1st and is available at: http://www.hcttf.org/resouces-tools . ...
(Date:7/1/2015)... ... July 01, 2015 , ... A ... just published a top ten list they hope will guide future mesothelioma research. ... to read it now. , More than 450 mesothelioma patients, caregivers, ...
Breaking Medicine News(10 mins):Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2
... Healthcare ... (PHI). The Health Information Technology for Economic and Clinical Health (HITECH) Act ups the ... solutions lend necessary expertise, manage compliance and allow the facility to maintain focus on ... ...
... , ... its international doctors meet or exceed all required qualifications and language competency. ... London, UK (PRWeb UK) June ... companies, today welcomed the British Medical Association ’s calls for a review of the ...
... ... presents beautiful diamond jewelry ornaments at wholesale prices directly to the public. ... (PRWEB) June 30, ... diamond watches presents beautiful Diamond Jewelry Accessories at wholesale prices directly to ...
... ... all 10 of its facilities in the Chicago area. OnShift enabled the company to reduce ... ... developers of nurse scheduling and employee communication software, recently announced it had been selected by ...
... at any point over the life course (teenage, age 30, age ... compared to those who are inactive, but teenage physical activity appears ... study of over nine thousand women published today in the ... growing evidence to suggest that people who are physically active in ...
... Researchers have been trying to determine the best strategy for ... recent meta-analysis shows that there is no one single intervention ... 29 in The Journal of the National Cancer Institute. ... reduce breast cancer mortality in women between the ages of ...
Cached Medicine News:Health News:Kroll Fraud Solutions' New HITECH Hotline Eases Burden of Data Breach Notification for Healthcare 2Health News:Kroll Fraud Solutions' New HITECH Hotline Eases Burden of Data Breach Notification for Healthcare 3Health News:Kroll Fraud Solutions' New HITECH Hotline Eases Burden of Data Breach Notification for Healthcare 4Health News:HCL Supports Reform of Language Testing for International Doctors 2Health News:HCL Supports Reform of Language Testing for International Doctors 3Health News:ItsHot.com Presents Aesthetic Diamond Jewelry and Diamond Watches at Wholesale Prices 2Health News:ItsHot.com Presents Aesthetic Diamond Jewelry and Diamond Watches at Wholesale Prices 3Health News:Lexington Health Care Chooses OnShift for Nurse Scheduling and Employee Communications in all Facilities 2Health News:Lexington Health Care Chooses OnShift for Nurse Scheduling and Employee Communications in all Facilities 3Health News:Teenage physical activity reduces risk of cognitive impairment in later life 2Health News:Interventions to promote repeat breast cancer screening with mammography 2
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
Medicine Products: